The incidence of esophageal cancer in patients with Asian Glow

Authors

DOI:

https://doi.org/10.33448/rsd-v11i17.38949

Keywords:

Incidence; Esophageal neoplasms; Aldehyde dehydrogenase; Asian glow.

Abstract

A deficiency of ALDH2 generates excess acetaldehyde, detecting signs and symptoms of facial flushing, also known as Asian Glow or Facial Flushing Syndrome. It is accompanied by nausea and headache, being considered a possible protective factor against alcoholism due to the clinical condition. This review aims to evaluate the relationship of Asian Glow with Esophageal Cancer and its influencing factors in the incidence of Asian pollution. A systematic review of the literature with free electronic access in the databases PubMed, Ministry of Health and Virtual Health Library (VHL), with a total number of 9 articles selected in the English language, filtering the articles related to the Asian cancer correlation. Applications for inclusion of publications of scientific articles in the period between 2009 and 2019. We conclude that the increase in alcohol consumption worldwide is directly related to a higher incidence of cancer in the world, especially in East Asian countries where a percentage of individuals with ALDH2 deficiency is high. Analyzing all four main points: the polymorphism of the genes encoding ALDH2, the Asian brightness, a tolerance to the manifestation of flushing and esophageal cancer (EC) we can reach a final result. EC is unrelated to Asian Glow, but it can cause ALDH2 which causes some patients with this syndrome.

References

Chang J S, Hsiao J R, & Chen C H. (2017). ALDH2 polymorphism and alcohol-related cancers in Asians: A public health perspective Tse-Hua Tan. J Biomed Sci. 24(1):1–10.

Yu C, Guo Y, Bian Z, Yang L, Millwood I Y, Walters R G, et al.(2018). Association of low-activity ALDH2 and alcohol consumption with risk of esophageal cancer in Chinese adults: A population-based cohort study. Int J Cancer. 143(7):1652–61.

Garcia S M N.(2009). Genes de metabolização do álcool e o risco de câncer de cabeça e pescoço.

Frare J C. (2015). Análise das características clinicopatológicas de carcinomas espinocelulares orais e pacientes jovens provenientes de Cascavel-Paraná. 57(01):26-28.

Monteiro T.(2016). Estudo sobre o polimorfismo dos genes álcool desidrogenase e aldeído desidrogenase (gene adh e aldh) e a dependência ao álcool em uma população da cidade de Goiânia-GO, Brasil.70.

Oze I, Matsuo K, Wakai K, Nagata C, Mizoue T, Tanaka K, et al. (2011). Alcohol drinking and esophageal cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 41(5):677–92.

Oze I, Matsuo K, Hosono S, Ito H, Kawase T, Watanabe M, et al. (2010). Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population. Cancer Sci.101 (8):1875–80.

Brooks P J, Enoch M A, Goldman D, Li T K, & Yokoyama A. (2009). The alcohol flushing response: An unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med.6(3):0258–63.

Yokoyama A, Yokoyama T, & Omori T. (2010). Past and current tendency for facial flushing after a small dose of alcohol is a marker for increased risk of upper aerodigestive tract cancer in Japanese drinkers. Cancer Sci.101(11):2497–8.

Van Hagen P, Hulshof M C C N, van Lanschot J J B, et al.(2012). Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med.;366:2074-84.

Mota F C, Cecconello I, Takeda F R, et al. (2018). Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options. Int J Surg. 2018;54(Pt A): 176-81.

Berger A C, Farma J, Scott W J, et al. (2005). Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol.23:4330-7.

Tatarian T, & Palazzo F. (2019). Chapter 35 − Epidemiology, Risk Factors, and Clinical Manifestations of Esophageal Cancer. In: Yeo CJ, editor. Shackelford’s Surgery of the Alimentary Tract. 2 vol. 8th ed. Philadelphia: Elsevier. p. 362-7.

World Health Organization. (2018). International Agency of Research on Cancer. Global Cancer Observatory. Cancer Today.

Guerra M R, Bustamante-Teixeira M T, Corrêa C S L, et al .(2017). Magnitude and variation of the burden of cancer mortality in Brazil and Federation Units, 1990 and 2015. Rev Bras Epidemiol. 20(Suppl 1):102-15.

Coleman H G, Xie S H, & Lagergren J. ( 2018). The Epidemiology of Esophageal Adenocarcinoma. Gastroenterology. 2018;154:390-405.

Arnold M, Soerjomataram I, Ferlay J, & Forman D. (2018). Global incidence of esophageal cancer by histological subtype in 2012. Gut. 2015;64:381-7.

Huang F L, & Yu SJ. (2016). Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 41:210-5.

National Comprehensive Cancer Network (NCCN). (2017). Guidelines, Esophageal Cancer, Version 1.2017.

Toneto M G, & Viola L. (2018). Current status of the multidisciplinary treatment of gastric adenocarcinoma. Arq Bras Cir Dig. 2018;31(2).

Published

23/12/2022

How to Cite

LOPES, C. M. .; SILVA, T. M. .; REZENDE , L. C. M. .; SILVA, L. V. B. .; CARVALHO, A. P. P. .; SILVA , M. P. F. da .; DAS GRAÇAS AMORIM VILELA , M.; FARIA, B. B. .; MESQUITA, F. S. C. .; GOULART, M. D. A. The incidence of esophageal cancer in patients with Asian Glow. Research, Society and Development, [S. l.], v. 11, n. 17, p. e150111738949, 2022. DOI: 10.33448/rsd-v11i17.38949. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/38949. Acesso em: 14 nov. 2024.

Issue

Section

Health Sciences